Notably, PAR-1 activation can exacerbate brain injury in stroke by promoting inflammation and blood-brain barrier dysfunction, while PAR-1 blockade has potential therapeutic benefits in reducing stroke-related damage and improving outcomes.As for PAR-4, its role in stroke is less well-defined. Here, F2R is linked to Stroke.